Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer
Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for “reader” proteins. The bromodomain (BRD) has long been thought to be the sole protein...
Saved in:
Published in | Genes & development Vol. 32; no. 1; pp. 58 - 69 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Cold Spring Harbor Laboratory Press
01.01.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for “reader” proteins. The bromodomain (BRD) has long been thought to be the sole protein module that recognizes acetylated histones. Recently, we identified the YEATS domain of AF9 (ALL1 fused gene from chromosome 9) as a novel acetyl-lysine-binding module and showed that the ENL (eleven-nineteen leukemia) YEATS domain is an essential acetyl-histone reader in acute myeloid leukemias. The human genome encodes four YEATS domain proteins, including GAS41, a component of chromatin remodelers responsible for H2A.Z deposition onto chromatin; however, the importance of the GAS41 YEATS domain in human cancer remains largely unknown. Here we report that
GAS41
is frequently amplified in human non-small cell lung cancer (NSCLC) and is required for cancer cell proliferation, survival, and transformation. Biochemical and crystal structural studies demonstrate that GAS41 binds to histone H3 acetylated on H3K27 and H3K14, a specificity that is distinct from that of AF9 or ENL. ChIP-seq (chromatin immunoprecipitation [ChIP] followed by high-throughput sequencing) analyses in lung cancer cells reveal that GAS41 colocalizes with H3K27ac and H3K14ac on the promoters of actively transcribed genes. Depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone variant H2A.Z with chromatin and consequently suppresses cancer cell growth and survival both in vitro and in vivo. Overall, our study identifies GAS41 as a histone acetylation reader that promotes histone H2A.Z deposition in NSCLC. |
---|---|
AbstractList | Hsu et al. show that depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone variant H2A.Z with chromatin and consequently suppresses cancer cell growth and survival.
Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for “reader” proteins. The bromodomain (BRD) has long been thought to be the sole protein module that recognizes acetylated histones. Recently, we identified the YEATS domain of AF9 (ALL1 fused gene from chromosome 9) as a novel acetyl-lysine-binding module and showed that the ENL (eleven-nineteen leukemia) YEATS domain is an essential acetyl-histone reader in acute myeloid leukemias. The human genome encodes four YEATS domain proteins, including GAS41, a component of chromatin remodelers responsible for H2A.Z deposition onto chromatin; however, the importance of the GAS41 YEATS domain in human cancer remains largely unknown. Here we report that
GAS41
is frequently amplified in human non-small cell lung cancer (NSCLC) and is required for cancer cell proliferation, survival, and transformation. Biochemical and crystal structural studies demonstrate that GAS41 binds to histone H3 acetylated on H3K27 and H3K14, a specificity that is distinct from that of AF9 or ENL. ChIP-seq (chromatin immunoprecipitation [ChIP] followed by high-throughput sequencing) analyses in lung cancer cells reveal that GAS41 colocalizes with H3K27ac and H3K14ac on the promoters of actively transcribed genes. Depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone variant H2A.Z with chromatin and consequently suppresses cancer cell growth and survival both in vitro and in vivo. Overall, our study identifies GAS41 as a histone acetylation reader that promotes histone H2A.Z deposition in NSCLC. Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for "reader" proteins. The bromodomain (BRD) has long been thought to be the sole protein module that recognizes acetylated histones. Recently, we identified the YEATS domain of AF9 (ALL1 fused gene from chromosome 9) as a novel acetyl-lysine-binding module and showed that the ENL (eleven-nineteen leukemia) YEATS domain is an essential acetyl-histone reader in acute myeloid leukemias. The human genome encodes four YEATS domain proteins, including GAS41, a component of chromatin remodelers responsible for H2A.Z deposition onto chromatin; however, the importance of the GAS41 YEATS domain in human cancer remains largely unknown. Here we report that GAS41 is frequently amplified in human non-small cell lung cancer (NSCLC) and is required for cancer cell proliferation, survival, and transformation. Biochemical and crystal structural studies demonstrate that GAS41 binds to histone H3 acetylated on H3K27 and H3K14, a specificity that is distinct from that of AF9 or ENL. ChIP-seq (chromatin immunoprecipitation [ChIP] followed by high-throughput sequencing) analyses in lung cancer cells reveal that GAS41 colocalizes with H3K27ac and H3K14ac on the promoters of actively transcribed genes. Depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone variant H2A.Z with chromatin and consequently suppresses cancer cell growth and survival both in vitro and in vivo. Overall, our study identifies GAS41 as a histone acetylation reader that promotes histone H2A.Z deposition in NSCLC.Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for "reader" proteins. The bromodomain (BRD) has long been thought to be the sole protein module that recognizes acetylated histones. Recently, we identified the YEATS domain of AF9 (ALL1 fused gene from chromosome 9) as a novel acetyl-lysine-binding module and showed that the ENL (eleven-nineteen leukemia) YEATS domain is an essential acetyl-histone reader in acute myeloid leukemias. The human genome encodes four YEATS domain proteins, including GAS41, a component of chromatin remodelers responsible for H2A.Z deposition onto chromatin; however, the importance of the GAS41 YEATS domain in human cancer remains largely unknown. Here we report that GAS41 is frequently amplified in human non-small cell lung cancer (NSCLC) and is required for cancer cell proliferation, survival, and transformation. Biochemical and crystal structural studies demonstrate that GAS41 binds to histone H3 acetylated on H3K27 and H3K14, a specificity that is distinct from that of AF9 or ENL. ChIP-seq (chromatin immunoprecipitation [ChIP] followed by high-throughput sequencing) analyses in lung cancer cells reveal that GAS41 colocalizes with H3K27ac and H3K14ac on the promoters of actively transcribed genes. Depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone variant H2A.Z with chromatin and consequently suppresses cancer cell growth and survival both in vitro and in vivo. Overall, our study identifies GAS41 as a histone acetylation reader that promotes histone H2A.Z deposition in NSCLC. Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for “reader” proteins. The bromodomain (BRD) has long been thought to be the sole protein module that recognizes acetylated histones. Recently, we identified the YEATS domain of AF9 (ALL1 fused gene from chromosome 9) as a novel acetyl-lysine-binding module and showed that the ENL (eleven-nineteen leukemia) YEATS domain is an essential acetyl-histone reader in acute myeloid leukemias. The human genome encodes four YEATS domain proteins, including GAS41, a component of chromatin remodelers responsible for H2A.Z deposition onto chromatin; however, the importance of the GAS41 YEATS domain in human cancer remains largely unknown. Here we report that GAS41 is frequently amplified in human non-small cell lung cancer (NSCLC) and is required for cancer cell proliferation, survival, and transformation. Biochemical and crystal structural studies demonstrate that GAS41 binds to histone H3 acetylated on H3K27 and H3K14, a specificity that is distinct from that of AF9 or ENL. ChIP-seq (chromatin immunoprecipitation [ChIP] followed by high-throughput sequencing) analyses in lung cancer cells reveal that GAS41 colocalizes with H3K27ac and H3K14ac on the promoters of actively transcribed genes. Depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone variant H2A.Z with chromatin and consequently suppresses cancer cell growth and survival both in vitro and in vivo. Overall, our study identifies GAS41 as a histone acetylation reader that promotes histone H2A.Z deposition in NSCLC. Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for "reader" proteins. The bromodomain (BRD) has long been thought to be the sole protein module that recognizes acetylated histones. Recently, we identified the YEATS domain of AF9 (ALL1 fused gene from chromosome 9) as a novel acetyl-lysine-binding module and showed that the ENL (eleven-nineteen leukemia) YEATS domain is an essential acetyl-histone reader in acute myeloid leukemias. The human genome encodes four YEATS domain proteins, including GAS41, a component of chromatin remodelers responsible for H2A.Z deposition onto chromatin; however, the importance of the GAS41 YEATS domain in human cancer remains largely unknown. Here we report that is frequently amplified in human non-small cell lung cancer (NSCLC) and is required for cancer cell proliferation, survival, and transformation. Biochemical and crystal structural studies demonstrate that GAS41 binds to histone H3 acetylated on H3K27 and H3K14, a specificity that is distinct from that of AF9 or ENL. ChIP-seq (chromatin immunoprecipitation [ChIP] followed by high-throughput sequencing) analyses in lung cancer cells reveal that GAS41 colocalizes with H3K27ac and H3K14ac on the promoters of actively transcribed genes. Depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone variant H2A.Z with chromatin and consequently suppresses cancer cell growth and survival both in vitro and in vivo. Overall, our study identifies GAS41 as a histone acetylation reader that promotes histone H2A.Z deposition in NSCLC. |
Author | Shi, Xiaobing Jiang, Shiming Hsu, Chih-Chao Shi, Jiejun Lyu, Jie Wen, Hong Yuan, Chao Wang, Xiaolu Li, Wei Zhao, Dan Li, Haitao |
AuthorAffiliation | 2 Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA 5 Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University, Beijing 100084, China 1 Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA 3 Dan L. Duncan Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA 4 MOE Key Laboratory of Protein Sciences, Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China 6 Genetics and Epigenetics Graduate Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas 77030, USA |
AuthorAffiliation_xml | – name: 2 Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA – name: 3 Dan L. Duncan Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA – name: 1 Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA – name: 5 Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University, Beijing 100084, China – name: 4 MOE Key Laboratory of Protein Sciences, Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China – name: 6 Genetics and Epigenetics Graduate Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas 77030, USA |
Author_xml | – sequence: 1 givenname: Chih-Chao surname: Hsu fullname: Hsu, Chih-Chao – sequence: 2 givenname: Jiejun surname: Shi fullname: Shi, Jiejun – sequence: 3 givenname: Chao surname: Yuan fullname: Yuan, Chao – sequence: 4 givenname: Dan surname: Zhao fullname: Zhao, Dan – sequence: 5 givenname: Shiming surname: Jiang fullname: Jiang, Shiming – sequence: 6 givenname: Jie surname: Lyu fullname: Lyu, Jie – sequence: 7 givenname: Xiaolu surname: Wang fullname: Wang, Xiaolu – sequence: 8 givenname: Haitao surname: Li fullname: Li, Haitao – sequence: 9 givenname: Hong surname: Wen fullname: Wen, Hong – sequence: 10 givenname: Wei surname: Li fullname: Li, Wei – sequence: 11 givenname: Xiaobing surname: Shi fullname: Shi, Xiaobing |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29437725$$D View this record in MEDLINE/PubMed |
BookMark | eNp1UctLBCEYlyhqe1w7hscus6mj43gJltgeEAQ9DnURdZxdY0a30Q32v8_aigq6KJ_f7-H3_XbBpg_eAnCI0RhjhE9mqhmXqOQ1zTXfACPMqCgY5XwTjFAtUCHKSuyA3RifEUIVqqptsEMELTknbATSrTVh5l1ywcPQwrmLKTtAZWxaderjWa9gmlt4MbmjGD5OJ_d3sAm9ch4uhtCHZCO8JJPxE2zsIsS1VG7mnxaxV10Hjc1Ht_QzaJQ3dtgHW63qoj34vPfAw_n0_uyyuL65uDqbXBeGsioVRhnW6For01qsUUW0EZbqttVEc0LqxljDGcuTNE0lmDKiRk2dQUqXnLW03AOna93FUvc2w30aVCcXg-vVsJJBOfm7491czsKrZDWpS8GywPGnwBBeljYm2bv4Po3yNiyjJAgRgkSFRYYe_fT6NvladQbQNcAMIcbBttK49LHgbO06iZF8T1TmROU60VzzTBv_oX0p_0N4A_5RpTQ |
CitedBy_id | crossref_primary_10_1007_s10528_024_10712_w crossref_primary_10_1007_s13402_022_00675_8 crossref_primary_10_1186_s13072_019_0274_9 crossref_primary_10_1016_j_cbpa_2023_102404 crossref_primary_10_1021_acs_jmedchem_2c01421 crossref_primary_10_3389_fonc_2021_701736 crossref_primary_10_3390_jdb10030028 crossref_primary_10_1016_j_molcel_2023_05_022 crossref_primary_10_1016_j_exphem_2023_06_001 crossref_primary_10_1016_j_phrs_2024_107283 crossref_primary_10_1002_pro_4533 crossref_primary_10_1021_acs_jmedchem_1c00367 crossref_primary_10_1073_pnas_2304103120 crossref_primary_10_1038_s41421_018_0027_0 crossref_primary_10_3389_fendo_2022_972312 crossref_primary_10_1101_gad_348904_121 crossref_primary_10_1016_j_bone_2024_117043 crossref_primary_10_3389_fonc_2024_1384928 crossref_primary_10_3389_fcell_2025_1497290 crossref_primary_10_3390_jpm10040267 crossref_primary_10_1016_j_bcp_2025_116747 crossref_primary_10_1021_acschembio_1c00945 crossref_primary_10_1016_j_lfs_2023_122059 crossref_primary_10_3389_fonc_2021_682762 crossref_primary_10_1084_jem_20182363 crossref_primary_10_1038_s41568_020_00330_0 crossref_primary_10_3389_fcell_2023_1192139 crossref_primary_10_1016_j_csbj_2021_12_027 crossref_primary_10_1016_j_bbagen_2023_130484 crossref_primary_10_1242_dev_201034 crossref_primary_10_1038_s41598_021_82206_3 crossref_primary_10_1002_cbin_11750 crossref_primary_10_1016_j_jbc_2022_102164 crossref_primary_10_3390_ijms21114002 crossref_primary_10_1016_j_gene_2020_144681 crossref_primary_10_1002_hep_31870 crossref_primary_10_1016_j_bmc_2021_116342 crossref_primary_10_1007_s00018_022_04218_0 crossref_primary_10_1038_s41421_019_0103_0 crossref_primary_10_1038_s41576_018_0072_4 crossref_primary_10_1016_j_jmb_2023_168376 crossref_primary_10_1016_j_humgen_2024_201300 crossref_primary_10_1021_acs_accounts_1c00463 crossref_primary_10_1021_acschembio_8b00674 crossref_primary_10_1038_s41467_025_57926_z crossref_primary_10_1101_gad_351444_123 crossref_primary_10_1093_nar_gkaa1130 crossref_primary_10_1002_advs_202310146 crossref_primary_10_1016_j_nlm_2020_107311 crossref_primary_10_3389_fimmu_2021_641883 crossref_primary_10_1038_s41598_019_50817_6 crossref_primary_10_1038_s41598_024_68348_0 crossref_primary_10_1002_2211_5463_13544 crossref_primary_10_1038_s41568_021_00357_x crossref_primary_10_1016_j_tibs_2022_04_014 crossref_primary_10_1038_s41576_024_00759_1 crossref_primary_10_1126_science_adl5816 crossref_primary_10_1038_s41580_021_00441_y crossref_primary_10_1021_acsmedchemlett_9b00460 crossref_primary_10_1186_s12964_024_01823_3 crossref_primary_10_3390_cells9112424 crossref_primary_10_1021_acschembio_4c00240 crossref_primary_10_3390_cancers13123003 crossref_primary_10_1021_acs_jpcb_1c00694 crossref_primary_10_4155_fmc_2020_0082 crossref_primary_10_1016_j_cbpa_2023_102334 crossref_primary_10_1038_s41586_021_03747_1 crossref_primary_10_1038_s41467_022_34861_x crossref_primary_10_1038_s41467_024_46857_w crossref_primary_10_2147_OTT_S243823 crossref_primary_10_1038_s41467_023_39735_4 crossref_primary_10_1016_j_ejmech_2023_115093 crossref_primary_10_2139_ssrn_3231848 crossref_primary_10_1002_advs_202307526 crossref_primary_10_1186_s12935_023_03098_z crossref_primary_10_1038_s42003_020_0898_0 crossref_primary_10_1021_jacs_0c10324 crossref_primary_10_1016_j_chembiol_2021_06_010 crossref_primary_10_1038_s41421_023_00640_1 crossref_primary_10_1111_1462_2920_15725 crossref_primary_10_1158_0008_5472_CAN_23_1836 crossref_primary_10_1039_D3NJ03738J crossref_primary_10_1158_2159_8290_CD_21_1307 crossref_primary_10_1007_s10142_023_00990_9 crossref_primary_10_1021_acscentsci_3c01419 crossref_primary_10_1177_2472555218809904 crossref_primary_10_1016_j_molcel_2022_11_002 crossref_primary_10_1101_gad_351318_123 crossref_primary_10_1111_nph_15737 crossref_primary_10_18632_aging_205497 |
Cites_doi | 10.1128/MCB.23.17.6086-6102.2003 10.1016/j.molcel.2015.05.009 10.1016/j.mad.2012.11.001 10.3791/51998 10.1038/cr.2016.49 10.1101/gad.1545707 10.1016/j.jmb.2012.10.004 10.1038/20974 10.1016/j.cell.2007.02.005 10.1126/science.1139004 10.1101/gr.118919.110 10.1074/jbc.C110.210211 10.1038/emboj.2010.85 10.1186/1756-8935-6-34 10.1038/nature04835 10.1038/47412 10.1016/j.molcel.2016.06.035 10.1007/s004390050271 10.1002/ijc.23380 10.1101/gad.188359.112 10.18632/oncotarget.7194 10.1186/1471-2164-13-424 10.1074/jbc.M806936200 10.1101/gad.1547707 10.1038/nsmb.1397 10.1126/science.1090701 10.1038/nprot.2008.211 10.1038/nature13045 10.1016/S0968-0004(99)01516-9 10.1126/science.1063127 10.1200/JCO.2012.46.9270 10.1074/jbc.C300389200 10.1186/gb-2008-9-9-r137 10.1101/gad.184705.111 10.1016/j.canlet.2007.10.032 10.1371/journal.pone.0010312 10.1038/s41467-017-01173-4 10.1074/jbc.M500001200 10.1093/hmg/6.11.1817 10.1128/MCB.19.1.855 10.1139/O08-111 10.2217/epi.14.22 10.1007/s00018-009-0199-8 10.1016/j.cell.2007.01.015 10.1158/0008-5472.CAN-04-3703 10.1038/nrm.2016.143 10.4161/epi.5.4.11520 10.1128/MCB.00804-09 10.1016/j.cell.2014.09.049 10.1128/MCB.02185-05 10.1038/nature21687 10.1074/jbc.M703418200 10.1158/0008-5472.CAN-13-1897 10.1371/journal.pbio.0020131 10.1073/pnas.0906539106 10.1016/S1097-2765(03)00497-0 10.1186/gb-2012-13-10-r85 10.1038/nature09139 |
ContentType | Journal Article |
Copyright | 2018 Hsu et al.; Published by Cold Spring Harbor Laboratory Press. 2018 |
Copyright_xml | – notice: 2018 Hsu et al.; Published by Cold Spring Harbor Laboratory Press. – notice: 2018 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1101/gad.303784.117 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Hsu et al |
EISSN | 1549-5477 |
EndPage | 69 |
ExternalDocumentID | PMC5828395 29437725 10_1101_gad_303784_117 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA193466 – fundername: NHGRI NIH HHS grantid: R01 HG007538 – fundername: NCI NIH HHS grantid: R01 CA204020 – fundername: CPRIT grantid: RP150292 – fundername: ; – fundername: Texas Tobacco Settlement – fundername: ; grantid: G1719 – fundername: ; grantid: 81602476 – fundername: National Post-doctoral Program for Innovative Talents grantid: BX201600088 – fundername: National Key R&D Program of China grantid: 2016YFA0500700 – fundername: ; grantid: R01HG007538; R01CA193466 – fundername: ; grantid: 31725014 – fundername: CPRIT grantid: RP160237; RP160739 |
GroupedDBID | --- -DZ -~X .55 18M 29H 2WC 39C 4.4 53G 5RE 5VS 85S AAYXX ABCQX ABDIX ACGFO ACLKE ACNCT ADBBV ADIYS ADXHL AECCQ AENEX AETEA AFFNX AFOSN AHPUY ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CITATION CS3 DIK DU5 E3Z EBS EJD F5P FRP GX1 H13 HYE H~9 IH2 KQ8 L7B MV1 N9A OK1 P2P R.V RCX RHI RPM SJN TAE TN5 TR2 UHB W8F WH7 WOQ X7M XSW YBU YHG YKV YSK CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c456t-cac5db8bacfe1b062bc9e4bffb2b7228dcec755377dd695ac980d8bc9ab375f43 |
ISSN | 0890-9369 1549-5477 |
IngestDate | Thu Aug 21 17:19:41 EDT 2025 Fri Jul 11 03:47:47 EDT 2025 Fri Mar 21 18:55:28 EDT 2025 Tue Jul 01 01:12:08 EDT 2025 Thu Apr 24 23:05:14 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | non-small cell lung cancer GAS41 H2A.Z YEATS domain histone acetylation |
Language | English |
License | 2018 Hsu et al.; Published by Cold Spring Harbor Laboratory Press. This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c456t-cac5db8bacfe1b062bc9e4bffb2b7228dcec755377dd695ac980d8bc9ab375f43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: Clinical Molecular Biology Laboratory, The Second Hospital of Shandong University, Jinan, Shandong 250033, China These authors contributed equally to this work. |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC5828395 |
PMID | 29437725 |
PQID | 2002209619 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5828395 proquest_miscellaneous_2002209619 pubmed_primary_29437725 crossref_citationtrail_10_1101_gad_303784_117 crossref_primary_10_1101_gad_303784_117 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-01-01 20180101 |
PublicationDateYYYYMMDD | 2018-01-01 |
PublicationDate_xml | – month: 01 year: 2018 text: 2018-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Genes & development |
PublicationTitleAlternate | Genes Dev |
PublicationYear | 2018 |
Publisher | Cold Spring Harbor Laboratory Press |
Publisher_xml | – name: Cold Spring Harbor Laboratory Press |
References | (2021111620065702000_32.1.58.42) 2009; 12 (2021111620065702000_32.1.58.47) 2015; 7 2021111620065702000_32.1.58.30 (2021111620065702000_32.1.58.58) 2016; 7 2021111620065702000_32.1.58.32 2021111620065702000_32.1.58.34 2021111620065702000_32.1.58.33 2021111620065702000_32.1.58.36 2021111620065702000_32.1.58.35 2021111620065702000_32.1.58.8 2021111620065702000_32.1.58.9 2021111620065702000_32.1.58.37 2021111620065702000_32.1.58.39 2021111620065702000_32.1.58.41 2021111620065702000_32.1.58.40 2021111620065702000_32.1.58.43 (2021111620065702000_32.1.58.52) 2017; 543 2021111620065702000_32.1.58.45 2021111620065702000_32.1.58.44 2021111620065702000_32.1.58.46 2021111620065702000_32.1.58.49 2021111620065702000_32.1.58.48 2021111620065702000_32.1.58.50 2021111620065702000_32.1.58.51 2021111620065702000_32.1.58.10 2021111620065702000_32.1.58.54 2021111620065702000_32.1.58.53 2021111620065702000_32.1.58.12 2021111620065702000_32.1.58.56 2021111620065702000_32.1.58.11 2021111620065702000_32.1.58.55 2021111620065702000_32.1.58.14 2021111620065702000_32.1.58.13 2021111620065702000_32.1.58.57 2021111620065702000_32.1.58.16 2021111620065702000_32.1.58.15 2021111620065702000_32.1.58.59 2021111620065702000_32.1.58.18 2021111620065702000_32.1.58.17 2021111620065702000_32.1.58.4 2021111620065702000_32.1.58.5 2021111620065702000_32.1.58.19 2021111620065702000_32.1.58.6 2021111620065702000_32.1.58.7 2021111620065702000_32.1.58.1 2021111620065702000_32.1.58.2 2021111620065702000_32.1.58.3 (2021111620065702000_32.1.58.24) 2012; 133 (2021111620065702000_32.1.58.31) 2017; 8 (2021111620065702000_32.1.58.61) 2016; 26 2021111620065702000_32.1.58.60 2021111620065702000_32.1.58.21 (2021111620065702000_32.1.58.38) 2011; 58 2021111620065702000_32.1.58.20 2021111620065702000_32.1.58.23 2021111620065702000_32.1.58.22 2021111620065702000_32.1.58.25 2021111620065702000_32.1.58.27 2021111620065702000_32.1.58.26 2021111620065702000_32.1.58.29 2021111620065702000_32.1.58.28 25408172 - J Vis Exp. 2014 Oct 27;(92):e51998 17671089 - Genes Dev. 2007 Aug 1;21(15):1869-81 15604268 - Cancer Res. 2004 Dec 15;64(24):9027-34 27103431 - Cell Res. 2016 May;26(5):629-32 25111486 - Epigenomics. 2014 Jun;6(3):329-39 24279307 - Epigenetics Chromatin. 2013 Oct 16;6(1):34 9302258 - Hum Mol Genet. 1997 Oct;6(11):1817-22 19936620 - Cell Mol Life Sci. 2010 Feb;67(4):611-28 17320507 - Cell. 2007 Feb 23;128(4):693-705 24170126 - Cancer Res. 2013 Dec 15;73(24):7301-12 22426530 - Genes Dev. 2012 Mar 15;26(6):527-41 21317290 - J Biol Chem. 2011 Apr 1;286(13):10911-7 28053347 - Nat Rev Mol Cell Biol. 2017 Apr;18(4):246-262 22920947 - BMC Genomics. 2012 Aug 24;13:424 14690608 - Mol Cell. 2003 Dec;12(6):1565-76 28241141 - Nature. 2017 Mar 9;543(7644):265-269 16705155 - Mol Cell Biol. 2006 Jun;26(11):4006-16 26051178 - Mol Cell. 2015 Jul 2;59(1):75-88 18327268 - Nat Struct Mol Biol. 2008 Apr;15(4):364-72 23034477 - Genome Biol. 2012 Oct 03;13(10):R85 19736624 - Curr Opin Drug Discov Devel. 2009 Sep;12(5):659-65 10637607 - Trends Biochem Sci. 2000 Jan;25(1):15-9 16728974 - Nature. 2006 Jul 6;442(7098):96-9 18160213 - Cancer Lett. 2008 Feb 18;260(1-2):37-47 22713874 - Genes Dev. 2012 Jun 15;26(12):1376-91 21788347 - Genome Res. 2012 Feb;22(2):307-21 25705384 - F1000Prime Rep. 2015 Jan 05;7:01 11498575 - Science. 2001 Aug 10;293(5532):1074-80 12963728 - J Biol Chem. 2003 Oct 31;278(44):42733-6 17617668 - J Biol Chem. 2007 Sep 7;282(36):26132-9 20351180 - Mol Cell Biol. 2010 Jun;30(11):2750-61 19966225 - Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21573-8 20473270 - EMBO J. 2010 Jun 16;29(12):2014-25 18838386 - J Biol Chem. 2008 Dec 5;283(49):33808-15 17320508 - Cell. 2007 Feb 23;128(4):707-19 15647280 - J Biol Chem. 2005 Apr 8;280(14 ):13665-70 27477906 - Mol Cell. 2016 Aug 4;63(3):470-84 14645854 - Science. 2004 Jan 16;303(5656):343-8 17510366 - Science. 2007 May 18;316(5827):1050-4 23401443 - J Clin Oncol. 2013 Mar 10;31(8):992-1001 25417107 - Cell. 2014 Oct 23;159(3):558-71 8882887 - Hum Genet. 1996 Nov;98(5):625-8 18214854 - Int J Cancer. 2008 May 15;122(10 ):2233-41 22068108 - Acta Biochim Pol. 2011;58(4):529-34 9858608 - Mol Cell Biol. 1999 Jan;19(1):855-63 23146670 - Mech Ageing Dev. 2012 Nov-Dec;133(11-12):686-94 10638745 - Nature. 2000 Jan 6;403(6765):41-5 23063713 - J Mol Biol. 2012 Dec 14;424(5):328-38 17575053 - Genes Dev. 2007 Jun 15;21(12):1519-29 18798982 - Genome Biol. 2008;9(9):R137 19234524 - Biochem Cell Biol. 2009 Feb;87(1):65-75 20364108 - Epigenetics. 2010 May 16;5(4):267-72 20613843 - Nature. 2010 Jul 8;466(7303):258-62 24590075 - Nature. 2014 Apr 10;508(7495):263-8 29057918 - Nat Commun. 2017 Oct 20;8(1):1088 12917332 - Mol Cell Biol. 2003 Sep;23(17):6086-102 20421987 - PLoS One. 2010 Apr 22;5(4):e10312 15045029 - PLoS Biol. 2004 May;2(5):E131 26863632 - Oncotarget. 2016 Mar 8;7(10 ):11412-23 10365964 - Nature. 1999 Jun 3;399(6735):491-6 19131956 - Nat Protoc. 2009;4(1):44-57 |
References_xml | – ident: 2021111620065702000_32.1.58.25 doi: 10.1128/MCB.23.17.6086-6102.2003 – ident: 2021111620065702000_32.1.58.51 doi: 10.1016/j.molcel.2015.05.009 – volume: 133 start-page: 686 year: 2012 ident: 2021111620065702000_32.1.58.24 article-title: Decrease of p400 ATPase complex and loss of H2A.Z within the p21 promoter occur in senescent IMR-90 human fibroblasts publication-title: Mech Ageing Dev doi: 10.1016/j.mad.2012.11.001 – volume: 58 start-page: 529 year: 2011 ident: 2021111620065702000_32.1.58.38 article-title: Direct interaction of Gas41 and Myc encoded by amplified genes in nervous system tumours publication-title: Acta Biochim Pol – ident: 2021111620065702000_32.1.58.2 doi: 10.3791/51998 – volume: 26 start-page: 629 year: 2016 ident: 2021111620065702000_32.1.58.61 article-title: YEATS2 is a selective histone crotonylation reader publication-title: Cell Res doi: 10.1038/cr.2016.49 – ident: 2021111620065702000_32.1.58.11 doi: 10.1101/gad.1545707 – ident: 2021111620065702000_32.1.58.1 doi: 10.1016/j.jmb.2012.10.004 – ident: 2021111620065702000_32.1.58.7 doi: 10.1038/20974 – ident: 2021111620065702000_32.1.58.21 doi: 10.1016/j.cell.2007.02.005 – volume: 12 start-page: 659 year: 2009 ident: 2021111620065702000_32.1.58.42 article-title: The role of human bromodomains in chromatin biology and gene transcription publication-title: Curr Opin Drug Discov Devel – ident: 2021111620065702000_32.1.58.27 doi: 10.1126/science.1139004 – ident: 2021111620065702000_32.1.58.50 doi: 10.1101/gr.118919.110 – ident: 2021111620065702000_32.1.58.36 doi: 10.1074/jbc.C110.210211 – ident: 2021111620065702000_32.1.58.6 doi: 10.1038/emboj.2010.85 – ident: 2021111620065702000_32.1.58.19 doi: 10.1186/1756-8935-6-34 – ident: 2021111620065702000_32.1.58.44 doi: 10.1038/nature04835 – ident: 2021111620065702000_32.1.58.46 doi: 10.1038/47412 – ident: 2021111620065702000_32.1.58.29 doi: 10.1016/j.molcel.2016.06.035 – ident: 2021111620065702000_32.1.58.8 doi: 10.1007/s004390050271 – ident: 2021111620065702000_32.1.58.15 doi: 10.1002/ijc.23380 – ident: 2021111620065702000_32.1.58.40 doi: 10.1101/gad.188359.112 – volume: 7 start-page: 11412 year: 2016 ident: 2021111620065702000_32.1.58.58 article-title: Oncogenic potential of histone-variant H2A.Z.1 and its regulatory role in cell cycle and epithelial-mesenchymal transition in liver cancer publication-title: Oncotarget doi: 10.18632/oncotarget.7194 – ident: 2021111620065702000_32.1.58.18 doi: 10.1186/1471-2164-13-424 – ident: 2021111620065702000_32.1.58.54 doi: 10.1074/jbc.M806936200 – ident: 2021111620065702000_32.1.58.17 doi: 10.1101/gad.1547707 – ident: 2021111620065702000_32.1.58.48 doi: 10.1038/nsmb.1397 – ident: 2021111620065702000_32.1.58.32 doi: 10.1126/science.1090701 – ident: 2021111620065702000_32.1.58.13 doi: 10.1038/nprot.2008.211 – ident: 2021111620065702000_32.1.58.56 doi: 10.1038/nature13045 – ident: 2021111620065702000_32.1.58.3 doi: 10.1016/S0968-0004(99)01516-9 – ident: 2021111620065702000_32.1.58.16 doi: 10.1126/science.1063127 – ident: 2021111620065702000_32.1.58.49 doi: 10.1200/JCO.2012.46.9270 – ident: 2021111620065702000_32.1.58.4 doi: 10.1074/jbc.C300389200 – ident: 2021111620065702000_32.1.58.60 doi: 10.1186/gb-2008-9-9-r137 – volume: 7 start-page: 01 year: 2015 ident: 2021111620065702000_32.1.58.47 article-title: H2A.Z: a molecular rheostat for transcriptional control publication-title: F1000prime Rep – ident: 2021111620065702000_32.1.58.45 doi: 10.1101/gad.184705.111 – ident: 2021111620065702000_32.1.58.37 doi: 10.1016/j.canlet.2007.10.032 – ident: 2021111620065702000_32.1.58.12 doi: 10.1371/journal.pone.0010312 – volume: 8 start-page: 1088 year: 2017 ident: 2021111620065702000_32.1.58.31 article-title: YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer publication-title: Nat Commun doi: 10.1038/s41467-017-01173-4 – ident: 2021111620065702000_32.1.58.5 doi: 10.1074/jbc.M500001200 – ident: 2021111620065702000_32.1.58.9 doi: 10.1093/hmg/6.11.1817 – ident: 2021111620065702000_32.1.58.14 doi: 10.1128/MCB.19.1.855 – ident: 2021111620065702000_32.1.58.43 doi: 10.1139/O08-111 – ident: 2021111620065702000_32.1.58.53 doi: 10.2217/epi.14.22 – ident: 2021111620065702000_32.1.58.33 doi: 10.1007/s00018-009-0199-8 – ident: 2021111620065702000_32.1.58.26 doi: 10.1016/j.cell.2007.01.015 – ident: 2021111620065702000_32.1.58.41 doi: 10.1158/0008-5472.CAN-04-3703 – ident: 2021111620065702000_32.1.58.10 doi: 10.1038/nrm.2016.143 – ident: 2021111620065702000_32.1.58.30 doi: 10.4161/epi.5.4.11520 – ident: 2021111620065702000_32.1.58.35 doi: 10.1128/MCB.00804-09 – ident: 2021111620065702000_32.1.58.28 doi: 10.1016/j.cell.2014.09.049 – ident: 2021111620065702000_32.1.58.34 doi: 10.1128/MCB.02185-05 – volume: 543 start-page: 265 year: 2017 ident: 2021111620065702000_32.1.58.52 article-title: ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia publication-title: Nature doi: 10.1038/nature21687 – ident: 2021111620065702000_32.1.58.57 doi: 10.1074/jbc.M703418200 – ident: 2021111620065702000_32.1.58.39 doi: 10.1158/0008-5472.CAN-13-1897 – ident: 2021111620065702000_32.1.58.20 doi: 10.1371/journal.pbio.0020131 – ident: 2021111620065702000_32.1.58.55 doi: 10.1073/pnas.0906539106 – ident: 2021111620065702000_32.1.58.22 doi: 10.1016/S1097-2765(03)00497-0 – ident: 2021111620065702000_32.1.58.23 doi: 10.1186/gb-2012-13-10-r85 – ident: 2021111620065702000_32.1.58.59 doi: 10.1038/nature09139 – reference: 17575053 - Genes Dev. 2007 Jun 15;21(12):1519-29 – reference: 17320507 - Cell. 2007 Feb 23;128(4):693-705 – reference: 19966225 - Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21573-8 – reference: 26863632 - Oncotarget. 2016 Mar 8;7(10 ):11412-23 – reference: 10365964 - Nature. 1999 Jun 3;399(6735):491-6 – reference: 25408172 - J Vis Exp. 2014 Oct 27;(92):e51998 – reference: 22920947 - BMC Genomics. 2012 Aug 24;13:424 – reference: 18838386 - J Biol Chem. 2008 Dec 5;283(49):33808-15 – reference: 24279307 - Epigenetics Chromatin. 2013 Oct 16;6(1):34 – reference: 19936620 - Cell Mol Life Sci. 2010 Feb;67(4):611-28 – reference: 18798982 - Genome Biol. 2008;9(9):R137 – reference: 23146670 - Mech Ageing Dev. 2012 Nov-Dec;133(11-12):686-94 – reference: 23401443 - J Clin Oncol. 2013 Mar 10;31(8):992-1001 – reference: 15647280 - J Biol Chem. 2005 Apr 8;280(14 ):13665-70 – reference: 8882887 - Hum Genet. 1996 Nov;98(5):625-8 – reference: 9302258 - Hum Mol Genet. 1997 Oct;6(11):1817-22 – reference: 14645854 - Science. 2004 Jan 16;303(5656):343-8 – reference: 23063713 - J Mol Biol. 2012 Dec 14;424(5):328-38 – reference: 20364108 - Epigenetics. 2010 May 16;5(4):267-72 – reference: 15604268 - Cancer Res. 2004 Dec 15;64(24):9027-34 – reference: 18327268 - Nat Struct Mol Biol. 2008 Apr;15(4):364-72 – reference: 20613843 - Nature. 2010 Jul 8;466(7303):258-62 – reference: 21788347 - Genome Res. 2012 Feb;22(2):307-21 – reference: 18214854 - Int J Cancer. 2008 May 15;122(10 ):2233-41 – reference: 10638745 - Nature. 2000 Jan 6;403(6765):41-5 – reference: 14690608 - Mol Cell. 2003 Dec;12(6):1565-76 – reference: 19234524 - Biochem Cell Biol. 2009 Feb;87(1):65-75 – reference: 25705384 - F1000Prime Rep. 2015 Jan 05;7:01 – reference: 26051178 - Mol Cell. 2015 Jul 2;59(1):75-88 – reference: 24590075 - Nature. 2014 Apr 10;508(7495):263-8 – reference: 16728974 - Nature. 2006 Jul 6;442(7098):96-9 – reference: 24170126 - Cancer Res. 2013 Dec 15;73(24):7301-12 – reference: 29057918 - Nat Commun. 2017 Oct 20;8(1):1088 – reference: 19131956 - Nat Protoc. 2009;4(1):44-57 – reference: 12963728 - J Biol Chem. 2003 Oct 31;278(44):42733-6 – reference: 17617668 - J Biol Chem. 2007 Sep 7;282(36):26132-9 – reference: 27103431 - Cell Res. 2016 May;26(5):629-32 – reference: 28053347 - Nat Rev Mol Cell Biol. 2017 Apr;18(4):246-262 – reference: 27477906 - Mol Cell. 2016 Aug 4;63(3):470-84 – reference: 17510366 - Science. 2007 May 18;316(5827):1050-4 – reference: 9858608 - Mol Cell Biol. 1999 Jan;19(1):855-63 – reference: 22713874 - Genes Dev. 2012 Jun 15;26(12):1376-91 – reference: 22068108 - Acta Biochim Pol. 2011;58(4):529-34 – reference: 23034477 - Genome Biol. 2012 Oct 03;13(10):R85 – reference: 11498575 - Science. 2001 Aug 10;293(5532):1074-80 – reference: 17671089 - Genes Dev. 2007 Aug 1;21(15):1869-81 – reference: 20351180 - Mol Cell Biol. 2010 Jun;30(11):2750-61 – reference: 16705155 - Mol Cell Biol. 2006 Jun;26(11):4006-16 – reference: 28241141 - Nature. 2017 Mar 9;543(7644):265-269 – reference: 15045029 - PLoS Biol. 2004 May;2(5):E131 – reference: 25111486 - Epigenomics. 2014 Jun;6(3):329-39 – reference: 18160213 - Cancer Lett. 2008 Feb 18;260(1-2):37-47 – reference: 12917332 - Mol Cell Biol. 2003 Sep;23(17):6086-102 – reference: 21317290 - J Biol Chem. 2011 Apr 1;286(13):10911-7 – reference: 20473270 - EMBO J. 2010 Jun 16;29(12):2014-25 – reference: 19736624 - Curr Opin Drug Discov Devel. 2009 Sep;12(5):659-65 – reference: 10637607 - Trends Biochem Sci. 2000 Jan;25(1):15-9 – reference: 20421987 - PLoS One. 2010 Apr 22;5(4):e10312 – reference: 17320508 - Cell. 2007 Feb 23;128(4):707-19 – reference: 25417107 - Cell. 2014 Oct 23;159(3):558-71 – reference: 22426530 - Genes Dev. 2012 Mar 15;26(6):527-41 |
SSID | ssj0006066 |
Score | 2.5451388 |
Snippet | Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of... Hsu et al. show that depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 58 |
SubjectTerms | Acetylation Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - metabolism Carcinoma, Non-Small-Cell Lung - pathology Cell Line, Tumor Cell Proliferation Gene Amplification Genes, cdc Histones - metabolism Histones - physiology Humans Lung Neoplasms - genetics Lung Neoplasms - metabolism Lung Neoplasms - pathology Promoter Regions, Genetic Protein Interaction Domains and Motifs Research Paper Transcription Factors - chemistry Transcription Factors - genetics Transcription Factors - metabolism Transcription Factors - physiology |
Title | Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29437725 https://www.proquest.com/docview/2002209619 https://pubmed.ncbi.nlm.nih.gov/PMC5828395 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKEBIviG_Kl4yExEPl0aZOYz9WY6gMwQPrpG0vVWzHtGhL0Zo8lL-CP5k723HTbUiDFytKbCf2_eK7853vCHkrrBUmTzNmFLeMCyikyRSzEsAjpSqGEk8jf_k6mhzxg-P0uNP53fJaqiu1q39de67kf6gK94CueEr2HygbO4UbcA30hRIoDOWNaPyt8f4JQh-GCSgxPkZRrb2Pm5MuEQnjQz7oneyPp4c9szzPF84zC8hUrHqTZLx7ii6xwX8Lt0DKZclW52i2xp393lmNR3MRIBdtaRZjVq8ceMzG9ygCZVV7e_5izvbm-TLu5bg0wr2DRfGjjsg8qfPG-h8rnsJ1OAXf3psYiNbeRFjCZJ9hykDPbcISyyVLeUjeEtbgzR5nxJpfUH1c98CafT9XF32XbOB7bnaBH2eCoyF6w94ak_4lrhd9EZ0W1B_MoP3Mt8cA6LfI7QQUD8yJ8eHT58jbUd1zekkYVwgDCu3fb79_W8y5ortcdsFtyTTT--ReUEbo2CPrAekU5UNyx6cnXT8iVQtfdGlpwBdt4YuqNQV8UYcv6vBFPb5ogy_q8EU3-KLwMOKLIr4o4ot6fD0mRx_3p3sTFrJ0MA3Cd8V0rlOjhMq1LQaqP0qUlgVX1qpEwQQKGKLO0nSYZcaMZJprKfpGQKVcDbPU8uETsgMvLZ4RCtNqBLBgqzMNijQXNgGFQmltR3IAinWXsGZSZzqEsMdMKmez64nYJe9i_Z8-eMtfa75paDSD9RWHnpfFsl5hmtYkwbxIskueeprFvhLJYVgJfFe2Rc1YAWO3bz8pF3MXwx2t1UOZPr_xF74gdzd_2EuyU13UxSuQhyv12kH0DxJ-teI |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recognition+of+histone+acetylation+by+the+GAS41+YEATS+domain+promotes+H2A.Z+deposition+in+non-small+cell+lung+cancer&rft.jtitle=Genes+%26+development&rft.au=Hsu%2C+Chih-Chao&rft.au=Shi%2C+Jiejun&rft.au=Yuan%2C+Chao&rft.au=Zhao%2C+Dan&rft.date=2018-01-01&rft.issn=0890-9369&rft.eissn=1549-5477&rft.volume=32&rft.issue=1&rft.spage=58&rft.epage=69&rft_id=info:doi/10.1101%2Fgad.303784.117&rft.externalDBID=n%2Fa&rft.externalDocID=10_1101_gad_303784_117 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0890-9369&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0890-9369&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0890-9369&client=summon |